Moffitt Cancer Center Expands Reimagine Care’s AI-Enabled Virtual Oncology Model

Why It Matters

The AI‑enabled virtual care model dramatically reduces unnecessary hospital visits and improves patient engagement, offering a scalable solution to oncology staffing shortages and rising cancer care costs.

Key Takeaways

• 97% of 7,000 interactions resolved without provider escalation
• Emergency department referrals dropped to 2.4% of digital contacts
• Six‑month retention hit 63%, triple typical digital health rates
• Patient satisfaction averaged 9.3/10, driven by AI assistant Remi
• Model expands across Moffitt locations to ease oncologist capacity constraints

Pulse Analysis

The surge in cancer diagnoses and increasingly complex treatment regimens have stretched oncology departments nationwide, leading to clinician burnout and limited appointment availability. Moffitt Cancer Center’s partnership with Reimagine Care introduces a hybrid virtual model that blends continuous home monitoring with a conversational AI assistant, Remi, and a dedicated remote clinical team. By embedding 24/7 oversight into patients’ daily lives, the platform shifts care from episodic, in‑person visits to proactive, data‑driven interactions, addressing symptom flare‑ups before they require emergency intervention.

The pilot phase logged nearly 7,000 digital encounters, with 97% resolved autonomously, sparing physicians from routine triage. Only 2.4% of interactions escalated to emergency department referrals, and 94% of acute symptom cases were managed entirely at home. Retention metrics shattered the industry norm: 99% engagement in month one, sustaining 63% after six months—more than three times the typical sub‑20% 90‑day drop‑off. Patient satisfaction averaged 9.3 out of 10, reflecting confidence in Remi’s empathetic dialogue and the rapid response of the virtual oncology team.

Scaling the AI‑enabled workflow to additional Moffitt campuses promises to alleviate oncologist capacity bottlenecks while preserving high‑quality care. Health systems observing these results can replicate the model, leveraging conversational AI to capture real‑time patient‑reported outcomes and trigger evidence‑based pathways without expanding staff headcount. Moreover, the reduction in avoidable emergency visits translates into measurable cost savings for payers and hospitals alike. As regulatory frameworks evolve to accommodate digital therapeutics, the Moffitt‑Reimagine Care collaboration sets a benchmark for integrating AI into chronic disease management, positioning virtual oncology as a mainstream component of future cancer care delivery.